# THE EFFECT OF LUMBRICUS RUBELLUS DLBS1033 EXTRACT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

> **NCT07684625** · PHASE4 · COMPLETED · sponsor: **Universitas Sebelas Maret** · enrollment: 60 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Oral Lumbricus Rubellus DLBS1033 (Low Dose)
- **DRUG:** Oral Lumbricus Rubellus DLBS1033 (High Dose)
- **OTHER:** Standard Diabetes Mellitus Therapy

## Key facts

- **NCT ID:** NCT07684625
- **Lead sponsor:** Universitas Sebelas Maret
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-03-01
- **Primary completion:** 2026-06-21
- **Final completion:** 2026-06-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07684625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07684625, "THE EFFECT OF LUMBRICUS RUBELLUS DLBS1033 EXTRACT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07684625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*